Archives

by in
Entry Author Date Location
‘Breakthrough’ in Quantified Health Sets Stage for Innovation Summit 03/22/12 San Diego
San Diego Life Sciences Roundup: Amylin, Optimer, and the Economy 02/03/12 San Diego
FDA Approvals for Alkermes & Vertex Among the NE Life Sciences News 02/03/12 Boston
Amylin, Alkermes Win FDA Approval of Once-Weekly Diabetes Drug 01/27/12 National
Novo Nordisk Adds Diabetes Research to Seattle Immunology Team 01/23/12 Seattle
Biotech Is Raising More Cash, But Don’t Be Fooled: Startups are Hurting 01/23/12 National
San Diego Life Sciences News: AnaptysBio, Life, NeuroGenetic & More 01/12/12 San Diego
Cebix to Raise $20 Million for Pivotal Trial of Diabetes Supplement 01/10/12 San Diego
Cure for Diabetes 12/28/11 San Francisco
Alkermes Spinoff, Civitas, Gets Michael J. Fox Support for Inhalable Parkinson’s Drug 11/29/11 Boston
Eli Lilly CEO John Lechleiter on Tackling the Pharmaceutical R&D Crisis (Part 2) 11/22/11 National
FDA Clears Portable Insulin Pump from San Diego’s Tandem Diabetes 11/16/11 San Diego
Turnaround CEO Shores Up Strategy for Unigene Based on Big Pharma Partnerships 11/15/11 New York
Rempex Raises $67.5M, Vertex Shares Tumble, & More San Diego Life Sciences News 11/10/11 San Diego
Merck Unveils Alzheimer’s and Diabetes Projects, Personnel Changes 11/10/11 New York
Rhythm Adds Former Merck VP as CEO 11/09/11 Boston
Amylin and Eli Lilly Part Ways on Diabetes Drug; Alkermes Deal Intact 11/08/11 San Diego
New Genzyme CEO, Biogen Scores in 2nd MS Pill Trial, Nanotech Drug Startups Nab Funds, & More Boston-Area Life Sciences News 10/28/11 Boston
BIND and Selecta Pull in $50M from Russian Fund Seeking to Advance Nano-Drugs 10/27/11 Boston
MPM-Backed Rhythm Advances Drug Programs in Diabetes and Obesity 10/25/11 Boston
Catabasis Begins Human Trials of Omega-3-Inspired Diabetes Treatment 10/20/11 Boston
Sofinnova Ventures Defies the Grim Mood, Raises $440M For Biotech-Only VC Fund 10/17/11 San Francisco
Tolerx Shutters, Courtagen Gets $8M, OvaScience Emerges, & More Boston-Area Life Sciences News 10/14/11 Boston
Report: Tolerx Folds Its Tent, After $150M in Investment and a Failed Diabetes Drug Trial 10/07/11 Boston
Sangamo Fails Diabetic Neuropathy Study, Falls Back on HIV, Other Programs 10/03/11 San Francisco
Elevation Partners Grabs $17M, NanoSort Wins Grants, NIH Collaborates with Afraxis on Rare Disease R&D, & More San Diego Life Sciences News 09/29/11 San Diego
AdverseEvents.com Seeks to Keep Track of Drug Side Effects the Way the FDA Never Could 09/27/11 San Francisco
Tensha Nabs $15M, Termeer Gives MIT $10M, Stata Puts $10M Into NABsys, & More Boston-Area Life Sciences News 09/16/11 Boston
GI Dynamics Starts Trading on Aussie Exchange, Eyes U.S. Pilot Study for Device in Diabetes and Obesity 09/14/11 Boston
Valeritas Raises $150M for Insulin Device 09/13/11 New York
Page 2 of 10 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  4. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  5. Do You Need an Extended Warranty? Do the Math, Says SquareTrade

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.